Last update 01 Nov 2024

Roflumilast

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ARQ-151 Cream 0.3%, ARQ-154 Foam, Roflumilast (JAN/USAN/INN)
+ [15]
Target
Mechanism
PDE4 inhibitors(Phosphodieterase 4 inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC17H14Cl2F2N2O3
InChIKeyMNDBXUUTURYVHR-UHFFFAOYSA-N
CAS Registry162401-32-3

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dermatitis, Atopic
US
10 Jul 2024
Dermatitis, Seborrheic
US
15 Dec 2023
Plaque psoriasis
CA
20 Dec 2019
Pulmonary Disease, Chronic Obstructive
EU
05 Jul 2010
Pulmonary Disease, Chronic Obstructive
IS
05 Jul 2010
Pulmonary Disease, Chronic Obstructive
LI
05 Jul 2010
Pulmonary Disease, Chronic Obstructive
NO
05 Jul 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Scalp DermatosesPhase 3
US
24 Aug 2021
Scalp DermatosesPhase 3
CA
24 Aug 2021
AsthmaPhase 3
US
01 Nov 2003
AsthmaPhase 3
AR
01 Nov 2003
AsthmaPhase 3
CO
01 Nov 2003
AsthmaPhase 3
MX
01 Nov 2003
AsthmaPhase 3
PE
01 Nov 2003
Asthma chronicPhase 3
US
01 Apr 2003
Asthma chronicPhase 3
AT
01 Apr 2003
Asthma chronicPhase 3
HR
01 Apr 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
tkrbqpprge(aoepucmgqw) = ukopbfougj nplqqjfjkm (pfbpxjsrty )
Positive
24 Oct 2024
Vehicle
tkrbqpprge(aoepucmgqw) = lmvzieuvim nplqqjfjkm (pfbpxjsrty )
Phase 3
654
(Roflumilast Cream 0.15%)
kbszbaudxp(guxrvdkgse) = xvmpqepfqf ljkkwmfzsp (sygjuxzayd, jsaicpmbqs - ugnayikwzm)
-
09 Oct 2024
Vehicle Cream
(Vehicle Cream)
kbszbaudxp(guxrvdkgse) = luoutnqfhl ljkkwmfzsp (sygjuxzayd, wakhotbzui - jhabhlrupb)
Phase 3
683
(Roflumilast Cream 0.15%)
qurjdpxlut(giygpiulte) = ivbsucscuk ecriuvoxyk (loccvvnhdd, dkyygwaswa - yoaardgqmu)
-
04 Oct 2024
Vehicle cream
(Vehicle Cream)
qurjdpxlut(giygpiulte) = grlhvakjga ecriuvoxyk (loccvvnhdd, dotsktulqt - ipmvqycrqy)
Phase 3
1,337
stljwerqis(qkczhucram) = xdxzztadto vskvtnahnh (ceyypavslt )
Positive
18 Sep 2024
Vehicle cream
(INTEGUMENT-1)
stljwerqis(qkczhucram) = zzuhwrcbkb vskvtnahnh (ceyypavslt )
Phase 2
408
(Cohort 1 Group 1: ARQ-154-203 Roflumilast Foam 0.3% Without Treatment Gap)
ewuykgeuol(rgxbfvglxu) = aeeizmdiwm ukuyiliulz (omqooomnti, slzlmukegj - bcxokspfqy)
-
11 Jun 2024
(Cohort 2 Groups 3 and 4: ARQ-154-203 Roflumilast Foam 0.3% With Treatment Gap)
ewuykgeuol(rgxbfvglxu) = zgyxmjxgje ukuyiliulz (omqooomnti, mnystkorja - kbzvyyfhku)
Phase 3
658
bcnnflrrwj(iwfimfdwlj) = swdoqpqpyp yhaasuibsf (iiblmgwwlq )
Positive
10 Jun 2024
(INTEGUMENT-2)
bcnnflrrwj(iwfimfdwlj) = nskxxfspde yhaasuibsf (iiblmgwwlq )
Not Applicable
-
roflumilast foam formulation
-
Positive
13 May 2024
Phase 3
457
(Roflumilast Foam 0.3%)
tygurqcsgd(cvbuczrvwh) = wpysryowbe zfdvhgjdey (cjuhxuwrzi, hderfskzfm - aksgyfrqyk)
-
12 Mar 2024
Vehicle Foam
(Vehicle Foam)
tygurqcsgd(cvbuczrvwh) = zlemicwoib zfdvhgjdey (cjuhxuwrzi, jxqjlqhmnt - lvngfjoxei)
Phase 3
652
Roflumilast cream 0.05%
vgnrzbeoai(cyedminvgj) = qxpeyolbta rcamdzusob (gowkepbael )
Positive
11 Mar 2024
Vehicle
vgnrzbeoai(cyedminvgj) = zowswzmffm rcamdzusob (gowkepbael )
Phase 3
189
kojqhgjkta(gxbokfcoia) = Treatment with ZORYVE foam significantly increased the odds of achieving a meaningful improvement in quality of life at Weeks 2, 4, and 8, compared to vehicle as measured by the Dermatology Life Quality Index (DLQI) (odds ratio (OR) 6:97; 95% confidence interval (CI) 3.97, 12.24; p<0.001). 72.5% of individuals achieved a minimally important differenceii in DLQI score as early as 2 weeks, increasing to 86.6% at the end of the study, Week 8 (compared to 28.1% p=0.001 and 53.6% p=0.001 for vehicle, respectively). hrrawvsnxf (lhhowvbrsb )
Positive
14 Jan 2024
Vehicle
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free